Risk adjustment and outcome research. Part I

被引:14
作者
Arca, Massimo [1 ]
Fusco, Danilo [1 ]
Barone, Anna P. [1 ]
Perucci, Carlo A. [1 ]
机构
[1] Local Hlth Author Rome E, Dept Epidemiol, I-00198 Rome, Italy
关键词
confounding factors; effect modifiers; outcome research; risk adjustment; risk factors; standardization; statistical models; treatment effectiveness;
D O I
10.2459/01.JCM.0000243002.67299.66
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The increasing demand for comparative evaluation of outcomes requires the development and diffusion of epidemiologic research, the ability to correctly formulate hypotheses, to conduct analyses and to interpret the results. The purpose of this paper is to provide a detailed but easy-reading review of epidemiologic methods to compare healthcare outcomes, particularly risk-adjustment methods. Methods The paper is divided into three parts. Part I describes confounding in observational studies, the ways confounding is identified and controlled (propensity adjustment and risk adjustment), and the methods for constructing the severity measures in risk-adjustment procedures. Conclusions It is becoming increasingly important for policy makers and planners to identify which factors may improve or worsen the effectiveness of treatments and services and to compare the performances of providers. Politicians, managers, epidemiologists, and clinicians should make their decisions based on the validity and precision of study results, by using the best scientific knowledge available. The statistical methods described in this review cannot measure 'reality' as it 'truly' is, but can produce 'images' of it, defining limits and uncertainties in terms of validity and precision. Studies that use credible risk-adjustment strategies are more likely to yield reliable and applicable findings. J Cardiovasc Med 7:682-690 (C) 2006 Italian Federation of Cardiology.
引用
收藏
页码:682 / 690
页数:9
相关论文
共 62 条
[1]  
*3M HLTH INF SYST, 3M ALL PAT REF DRG
[2]  
[Anonymous], 2003, APPL MIXED MODELS ME
[3]   A comparison of observational studies and randomized, controlled trials. [J].
Benson, K ;
Hartz, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1878-1886
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]  
Clayton D., 1993, STAT MODELS EPIDEMIO
[6]  
Deeks JJ., 2003, HEALTH TECHNOL ASSES, V7, pIII, DOI DOI 10.3310/HTA7270
[7]  
DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO
[8]  
2-D
[9]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845
[10]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619